CALDER_PHARMACY_LIMITED - Accounts

Company Registration No. SC268645 (Scotland)
CALDER PHARMACY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2019
PAGES FOR FILING WITH REGISTRAR
CALDER PHARMACY LIMITED
COMPANY INFORMATION
Director
Mr C Shanks
Secretary
Ms D Holmes
Company number
SC268645
Registered office
18 Calder Park
Edinburgh
EH11 4JN
Accountants
Geoghegans Accountancy Limited
Chartered Accountants
6 St Colme Street
Edinburgh
EH3 6AD
CALDER PHARMACY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 9
CALDER PHARMACY LIMITED
BALANCE SHEET
AS AT
31 AUGUST 2019
31 August 2019
- 1 -
2019
2018
Notes
£
£
£
£
Fixed assets
Intangible assets
73,000
87,600
Tangible assets
4
76,803
12,347
Investment properties
5
340,404
336,404
Investments
6
20,196
29,585
510,403
465,936
Current assets
Stocks
18,197
17,233
Debtors
7
218,055
298,948
Cash at bank and in hand
204,640
148,402
440,892
464,583
Creditors: amounts falling due within one year
8
(67,386)
(107,259)
Net current assets
373,506
357,324
Total assets less current liabilities
883,909
823,260
Creditors: amounts falling due after more than one year
9
(227,199)
(224,731)
Provisions for liabilities
(13,057)
(1,953)
Net assets
643,653
596,576
Capital and reserves
Called up share capital
10
1,000
1,000
Profit and loss reserves (non-distributable)
18,506
14,535
Profit and loss reserves
624,147
581,041
Total equity
643,653
596,576

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 August 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

CALDER PHARMACY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 AUGUST 2019
31 August 2019
- 2 -

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 21 November 2019
Mr C  Shanks
Director
Company Registration No. SC268645
CALDER PHARMACY LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2019
- 3 -
Share capital
Other reserves
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 September 2017
1,000
1,225
537,192
539,417
Year ended 31 August 2018:
Profit and total comprehensive income for the year
-
-
148,159
148,159
Dividends
-
-
(91,000)
(91,000)
Transfers
-
-
(13,310)
(13,310)
Other movements
-
13,310
-
13,310
Balance at 31 August 2018
1,000
14,535
581,041
596,576
Year ended 31 August 2019:
Profit and total comprehensive income for the year
-
-
138,077
138,077
Dividends
-
-
(91,000)
(91,000)
Transfers
-
-
(3,971)
(3,971)
Net unrealised gains/(losses)
-
3,971
-
3,971
Balance at 31 August 2019
1,000
18,506
624,147
643,653
CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2019
- 4 -
1
Accounting policies
Company information

Calder Pharmacy Limited is a private company limited by shares incorporated in Scotland. The registered office is 18 Calder Park, Edinburgh, EH11 4JN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
15% on reducing balance
Motor vehicles

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Investment properties

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

 

Where fair value cannot be achieved without undue cost or effort, investment property is accounted for as tangible fixed assets.

CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2019
1
Accounting policies
(Continued)
- 5 -
1.6
Impairment of fixed assets

The carrying value of tangible fixed assets are reviewed for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable.

1.7
Stocks

Stocks are stated at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost is determined on a first-in. first-out basis. Net realisable value is based on estimated selling price, less any further costs of realisation.

1.8
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Debtors

Debtors with no stated interest rate or receivable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Creditors

Creditors with no stated interest rate and payable within one year are recorded at transaction price.

 

All interest bearing loans and borrowings which are basic financial instruments are initially recorded at the present value of cash payable. After initial recognition they are measured at amortised cost.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2019
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.15
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 8 (2018 - 8).

CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2019
- 7 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 September 2018 and 31 August 2019
292,000
Amortisation and impairment
At 1 September 2018
204,400
Amortisation charged for the year
14,600
At 31 August 2019
219,000
Carrying amount
At 31 August 2019
73,000
At 31 August 2018
87,600
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 September 2018
36,684
Additions
74,033
At 31 August 2019
110,717
Depreciation and impairment
At 1 September 2018
24,337
Depreciation charged in the year
9,577
At 31 August 2019
33,914
Carrying amount
At 31 August 2019
76,803
At 31 August 2018
12,347
5
Investment property
2019
£
Fair value
At 1 September 2018
336,404
Revaluations
4,000
At 31 August 2019
340,404
CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2019
5
Investment property
(Continued)
- 8 -

Investment property comprises two properties held to earn rental income.

6
Fixed asset investments
2019
2018
£
£
Investments
20,196
29,585
Movements in fixed asset investments
Investments other than loans
£
Cost or valuation
At 1 September 2018
29,585
Additions
60
Disposals
(9,449)
At 31 August 2019
20,196
Carrying amount
At 31 August 2019
20,196
At 31 August 2018
29,585
7
Debtors
2019
2018
Amounts falling due within one year:
£
£
Trade debtors
70,170
87,456
Corporation tax and other taxation
7,760
-
Other debtors
140,125
211,492
218,055
298,948
CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2019
- 9 -
8
Creditors: amounts falling due within one year
2019
2018
£
£
Bank loans and overdrafts
28,049
25,285
Trade creditors
31,676
56,314
Corporation tax, other taxation and social security
1,008
20,550
Other creditors
6,653
5,110
67,386
107,259
9
Creditors: amounts falling due after more than one year
2019
2018
£
£
Bank loans and overdrafts
227,199
224,731

The aggregate amount of creditors for which security has been given amounted to £226,959 (2018 - £250,016).

 

The Royal Bank of Scotland PLC has a bond and floating charge over the undertaking and all property and assets present and future.

 

The Royal Bank of Scotland PLC holds a fixed charge over the property at Leyland Road and another over the property at Sighthill Park.

10
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and fully paid
1,000 Ordinary Shares of £1 each
1,000
1,000
11
Related party transactions

Included in other debtors is a balance of £104,009 (2018: £157,400) owed by Mr C Shanks, director of the company. Interest is charged at 2.5%.

2019-08-312018-09-01false21 November 2019CCH SoftwareCCH Accounts Production 2019.301No description of principal activityMr C ShanksMs D HolmesSC2686452018-09-012019-08-31SC268645bus:Director12018-09-012019-08-31SC268645bus:CompanySecretary12018-09-012019-08-31SC268645bus:RegisteredOffice2018-09-012019-08-31SC2686452019-08-31SC268645core:NetGoodwill2019-08-31SC268645core:NetGoodwill2018-08-31SC2686452017-09-012018-08-31SC2686452018-08-31SC268645core:OtherPropertyPlantEquipment2019-08-31SC268645core:OtherPropertyPlantEquipment2018-08-31SC268645core:CurrentFinancialInstrumentscore:WithinOneYear2019-08-31SC268645core:CurrentFinancialInstrumentscore:WithinOneYear2018-08-31SC268645core:CurrentFinancialInstruments2019-08-31SC268645core:CurrentFinancialInstruments2018-08-31SC268645core:Non-currentFinancialInstruments2019-08-31SC268645core:Non-currentFinancialInstruments2018-08-31SC268645core:ShareCapital2019-08-31SC268645core:ShareCapital2018-08-31SC268645core:OtherMiscellaneousReserve2019-08-31SC268645core:OtherMiscellaneousReserve2018-08-31SC268645core:RetainedEarningsAccumulatedLosses2019-08-31SC268645core:RetainedEarningsAccumulatedLosses2018-08-31SC268645core:RetainedEarningsAccumulatedLosses2017-09-012018-08-31SC268645core:RetainedEarningsAccumulatedLosses2018-09-012019-08-31SC268645core:Goodwill2018-09-012019-08-31SC268645core:FurnitureFittings2018-09-012019-08-31SC268645core:NetGoodwill2018-08-31SC268645core:NetGoodwill2018-09-012019-08-31SC268645core:OtherPropertyPlantEquipment2018-08-31SC268645core:OtherPropertyPlantEquipment2018-09-012019-08-31SC2686452018-08-31SC268645core:WithinOneYear2019-08-31SC268645core:WithinOneYear2018-08-31SC268645bus:PrivateLimitedCompanyLtd2018-09-012019-08-31SC268645bus:SmallCompaniesRegimeForAccounts2018-09-012019-08-31SC268645bus:FRS1022018-09-012019-08-31SC268645bus:AuditExemptWithAccountantsReport2018-09-012019-08-31SC268645bus:FullAccounts2018-09-012019-08-31xbrli:purexbrli:sharesiso4217:GBP